54 related articles for article (PubMed ID: 20369484)
1. [Changes of plasma uPA and TGF-beta1 in patients with preeclampsia].
Wang XJ; Zhou ZY; Xu YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):118-20. PubMed ID: 20369484
[TBL] [Abstract][Full Text] [Related]
2. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.
Peraçoli MT; Menegon FT; Borges VT; de Araújo Costa RA; Thomazini-Santos IA; Peraçoli JC
J Reprod Immunol; 2008 Oct; 79(1):79-84. PubMed ID: 18805591
[TBL] [Abstract][Full Text] [Related]
3. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation.
Muy-Rivera M; Sanchez SE; Vadachkoria S; Qiu C; Bazul V; Williams MA
Am J Hypertens; 2004 Apr; 17(4):334-8. PubMed ID: 15062887
[TBL] [Abstract][Full Text] [Related]
5. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
[TBL] [Abstract][Full Text] [Related]
6. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?
Clausen T; Djurovic S; Reseland JE; Berg K; Drevon CA; Henriksen T
Placenta; 2002 May; 23(5):380-5. PubMed ID: 12061853
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
Ayatollahi M; Geramizadeh B; Samsami A
Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
[TBL] [Abstract][Full Text] [Related]
8. Local activation of TGF-beta1 at endometriosis sites.
Komiyama S; Aoki D; Komiyama M; Nozawa S
J Reprod Med; 2007 Apr; 52(4):306-12. PubMed ID: 17506371
[TBL] [Abstract][Full Text] [Related]
9. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
10. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms.
Lindholt JS; Jørgensen B; Shi GP; Henneberg EW
Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):546-51. PubMed ID: 12787697
[TBL] [Abstract][Full Text] [Related]
11. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
Naicker T; Khedun SM; Moodley J
J Obstet Gynaecol; 2002 May; 22(3):279-82. PubMed ID: 12521499
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
[TBL] [Abstract][Full Text] [Related]
16. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
17. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
[TBL] [Abstract][Full Text] [Related]
19. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.
Xu G; Chakraborty C; Lala PK
Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587
[TBL] [Abstract][Full Text] [Related]
20. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.
Philippou A; Maridaki M; Koutsilieris M
In Vivo; 2008; 22(6):735-50. PubMed ID: 19181000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]